Ample investigations have shown that genetic ablation of Nrf2 worsens the inflammation and increases the oxidative stress in numerous disease models, including pulmonary fibrosis (50), sepsis (51), acute lung injury (52), COPD exacerbations (53), and emphysema (54). The gene discussed is NFE2L2; the disease is pulmonary fibrosis.